NMR Imaging of the Human Brain-Insights into Neurological Diseases
Clinical efficacy of diagnosis.
Quality of treatment that results from diagnosis.
Outcome of that treatment; i.e., though there may be more efficacious diagnosis and even easier or more rational types of therapy, has this resulted in any better outcome for a given disease process?
Increased knowledge of the pathophysiology of a disease process, so that better forms of therapy might be available in the future.
The potential lack of specificity of MR findings, requiring more tests.
The diseases in which other tests may prove more efficacious.
The limiting factors in the overall treatment of and outcome from a particular disease; i.e., it may be that therapeutic modalities available today are simply not up to the level of the diagnosis, or that we may be imaging the anatomical changes from a disease that is not based on an anatomical abnormality, and therefore requires far better understanding of the underlying pathophysiology for appropriate therapy.
KeywordsIschemia Attenuation Cobalt Adenoma Dementia
Unable to display preview. Download preview PDF.
- 1.Brant-Zawadzki M and Norman D, eds. (1987) Magnetic resonance imaging of the central nervous system. Raven Press, New York.Google Scholar
- 2.Gomori JM, Grossman RE and Goldberg Hi (1985) Intracranial hematomas: imaging by high-field MR. Radiology, 157:87–93.Google Scholar
- 3.Hilal SK, Maudsley AA and Simon HE (1983) In vivo NMR imaging of tissue sodium in the intact cat before and after acute cerebral stroke. AJNR 4:245–249.Google Scholar
- 4.Latchaw RE, ed (1985) Computed tomography of the head, neck and spine. Year Book Medical Publishers, Chicago.Google Scholar
- 5.Lunsford ID, Martinez AJ and Latchaw RE (1986) Magnetic resonance imaging does not define tumor boundaries. Acta Radiol 369:154–156.Google Scholar
- 6.Stark DD and Bradley WG, eds. (1988) Magnetic resonance imaging. C.V. Mosby, St. Louis.Google Scholar